United Kingdom and U.S. researchers have jointly developed a simple and feasible technique for early diagnosis of liver disease, which will take 30 to 45 minutes to help prevent liver disease from reaching a fatal stage. Rosenberg, a professor at the University College London, who participated in the study, said that the main problem of liver disease is "no clinical symptoms." It is often too late to detect the liver disease, and it is impossible to reverse the injury. The degree of hepatic fibrosis is a sign of liver damage. A team of researchers from University College London and the University of Massachusetts at Amherst designed a sensor that contains macromolecules coated with fluorescent agents. Proteins in the blood of healthy people, early-stage liver fibrosis patients, and late-stage patients encounter such macromolecules, enabling the phosphors to exhibit different colors and brightness. Blood tests using this sensor only require a small amount of blood, which means that the cost is low and the procedure is simple. The experimental results show that the accuracy rate of using this sensor to distinguish between healthy people and liver fibrosis patients is 80%, and the accuracy rate of distinguishing between mild to moderate hepatic fibrosis and severe hepatic fibrosis is 60%. The researchers said that they will improve this technique for detecting liver fibrosis and increase the accuracy rate, hoping that one day it will be applied to daily inspections. (According to Xinhua News Agency) Vitamins,Vitamin B5,Vitamin D,Vitamin B4,Vitamin K PYSON Co. ,Ltd. , https://www.pysonbio.com